228 related articles for article (PubMed ID: 18564357)
21. The presence of alpha-thalassaemia trait blunts the response to hydroxycarbamide in patients with sickle cell disease.
Vasavda N; Badiger S; Rees D; Height S; Howard J; Thein SL
Br J Haematol; 2008 Nov; 143(4):589-92. PubMed ID: 18764867
[TBL] [Abstract][Full Text] [Related]
22. PDE9A, PDE10A, and PDE11A expression in rat trigeminovascular pain signalling system.
Kruse LS; Møller M; Tibaek M; Gammeltoft S; Olesen J; Kruuse C
Brain Res; 2009 Jul; 1281():25-34. PubMed ID: 19445908
[TBL] [Abstract][Full Text] [Related]
23. Circulating endothelin-3 levels in patients with sickle cell disease during hydroxyurea treatment.
Makis AC; Hatzimichael EC; Kolios G; Bourantas KL
Haematologica; 2004 Mar; 89(3):360-1. PubMed ID: 15020278
[TBL] [Abstract][Full Text] [Related]
24. Phosphodiesterase 9A controls nitric-oxide-independent cGMP and hypertrophic heart disease.
Lee DI; Zhu G; Sasaki T; Cho GS; Hamdani N; Holewinski R; Jo SH; Danner T; Zhang M; Rainer PP; Bedja D; Kirk JA; Ranek MJ; Dostmann WR; Kwon C; Margulies KB; Van Eyk JE; Paulus WJ; Takimoto E; Kass DA
Nature; 2015 Mar; 519(7544):472-6. PubMed ID: 25799991
[TBL] [Abstract][Full Text] [Related]
25. Hydrolysis of the non-canonical cyclic nucleotide cUMP by PDE9A: kinetics and binding mode.
Scharrenbroich J; Kaever V; Dove S; Seifert R; Schneider EH
Naunyn Schmiedebergs Arch Pharmacol; 2019 Feb; 392(2):199-208. PubMed ID: 30443663
[TBL] [Abstract][Full Text] [Related]
26. Inhibition of acetylcholinesterase and phosphodiesterase-9A has differential effects on hippocampal early and late LTP.
Kroker KS; Rast G; Giovannini R; Marti A; Dorner-Ciossek C; Rosenbrock H
Neuropharmacology; 2012 Apr; 62(5-6):1964-74. PubMed ID: 22245562
[TBL] [Abstract][Full Text] [Related]
27. Modulation of redox pathways in neutrophils from sickle cell disease patients.
Aslan M; Canatan D
Exp Hematol; 2008 Nov; 36(11):1535-44. PubMed ID: 18809239
[TBL] [Abstract][Full Text] [Related]
28. Identification of phosphodiesterase 9A as a cyclic guanosine monophosphate-specific phosphodiesterase in germinal vesicle oocytes: a proposed role in the resumption of meiosis.
Hanna CB; Yao S; Wu X; Jensen JT
Fertil Steril; 2012 Aug; 98(2):487-95.e1. PubMed ID: 22704629
[TBL] [Abstract][Full Text] [Related]
29. Increased adhesive properties of platelets in sickle cell disease: roles for alphaIIb beta3-mediated ligand binding, diminished cAMP signalling and increased phosphodiesterase 3A activity.
Proença-Ferreira R; Franco-Penteado CF; Traina F; Saad ST; Costa FF; Conran N
Br J Haematol; 2010 Apr; 149(2):280-8. PubMed ID: 20136824
[TBL] [Abstract][Full Text] [Related]
30. Modulation of erythroid adhesion receptor expression by hydroxyurea in children with sickle cell disease.
Odièvre MH; Bony V; Benkerrou M; Lapouméroulie C; Alberti C; Ducrocq R; Jacqz-Aigrain E; Elion J; Cartron JP
Haematologica; 2008 Apr; 93(4):502-10. PubMed ID: 18322255
[TBL] [Abstract][Full Text] [Related]
31. Identification of a brain penetrant PDE9A inhibitor utilizing prospective design and chemical enablement as a rapid lead optimization strategy.
Verhoest PR; Proulx-Lafrance C; Corman M; Chenard L; Helal CJ; Hou X; Kleiman R; Liu S; Marr E; Menniti FS; Schmidt CJ; Vanase-Frawley M; Schmidt AW; Williams RD; Nelson FR; Fonseca KR; Liras S
J Med Chem; 2009 Dec; 52(24):7946-9. PubMed ID: 19919087
[TBL] [Abstract][Full Text] [Related]
32. Phosphodiesterase 9a Inhibition in Mouse Models of Diastolic Dysfunction.
Methawasin M; Strom J; Borkowski T; Hourani Z; Runyan R; Smith JE; Granzier H
Circ Heart Fail; 2020 May; 13(5):e006609. PubMed ID: 32418479
[TBL] [Abstract][Full Text] [Related]
33. Nitric oxide and cyclic GMP levels in sickle cell patients receiving hydroxyurea.
Nahavandi M; Tavakkoli F; Wyche MQ; Perlin E; Winter WP; Castro O
Br J Haematol; 2002 Dec; 119(3):855-7. PubMed ID: 12437671
[TBL] [Abstract][Full Text] [Related]
34. PDE9A deficiency does not prevent chronic-hypoxic pulmonary hypertension in mice.
Kolb TM; Johnston L; Damarla M; Kass DA; Hassoun PM
Physiol Rep; 2021 Sep; 9(18):e15057. PubMed ID: 34569183
[TBL] [Abstract][Full Text] [Related]
35. Role of cyclic nucleotides in fetal hemoglobin induction in cultured CD34+ cells.
Keefer JR; Schneidereith TA; Mays A; Purvis SH; Dover GJ; Smith KD
Exp Hematol; 2006 Sep; 34(9):1151-61. PubMed ID: 16939808
[TBL] [Abstract][Full Text] [Related]
36. Hydroxycarbamide stimulates the production of proinflammatory cytokines by endothelial cells: relevance to sickle cell disease.
Laurance S; Pellay FX; Dossou-Yovo OP; Verger E; Krishnamoorthy R; Lapoumeroulie C; Benecke A; Elion J
Pharmacogenet Genomics; 2010 Apr; 20(4):257-68. PubMed ID: 20216336
[TBL] [Abstract][Full Text] [Related]
37. The Rv0805 gene from Mycobacterium tuberculosis encodes a 3',5'-cyclic nucleotide phosphodiesterase: biochemical and mutational analysis.
Shenoy AR; Sreenath N; Podobnik M; Kovacevic M; Visweswariah SS
Biochemistry; 2005 Dec; 44(48):15695-704. PubMed ID: 16313172
[TBL] [Abstract][Full Text] [Related]
38. Immunohistochemical distribution of cAMP- and cGMP-phosphodiesterase (PDE) isoenzymes in the human prostate.
Uckert S; Oelke M; Stief CG; Andersson KE; Jonas U; Hedlund P
Eur Urol; 2006 Apr; 49(4):740-5. PubMed ID: 16460876
[TBL] [Abstract][Full Text] [Related]
39. The acceleration of the propagation phase of thrombin generation in patients with steady-state sickle cell disease is associated with circulating erythrocyte-derived microparticles.
Gerotziafas GT; Van Dreden P; Chaari M; Galea V; Khaterchi A; Lionnet F; Stankovic-Stojanovic K; Blanc-Brude O; Woodhams B; Maier-Redelsperger M; Girot R; Hatmi M; Elalamy I
Thromb Haemost; 2012 Jun; 107(6):1044-52. PubMed ID: 22535498
[TBL] [Abstract][Full Text] [Related]
40. Effects of hydroxyurea on the membrane of erythrocytes and platelets in sickle cell anemia.
Covas DT; de Lucena Angulo I; Vianna Bonini Palma P; Zago MA
Haematologica; 2004 Mar; 89(3):273-80. PubMed ID: 15020264
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
